LOADING
Comparing AbbVie Inc (ABBV) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | QCOM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $450.6B | $188.9B |
| P/E Ratio | 70.8 | 20.2 |
| Forward P/E | 15.5 | 17.4 |
| PEG Ratio | 0.36 | 0.78 |
| EPS | $3.60 | $8.77 |
| Revenue Growth (YoY) | 10.2% | -4.0% |
| Profit Margin | 9.8% | 21.0% |
| Return on Equity | 62.3% | 33.8% |
| Dividend Yield | 2.72% | 2.04% |
| Beta | 0.28 | 1.68 |
| 52-Week High | $267.47 | $257.56 |
| 52-Week Low | $189.40 | $120.88 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.